Search Results Search Sort by RelevanceMost Recent Case and Commentary Jul 2021 How Should Clinicians Minimize Harms and Maximize Benefits When Diagnosing and Treating Disorders Without Biomarkers? Benjamin Tolchin, MD, MS, Dorothy W. Tolchin, MD, EdM, and Michael Ashley Stein, JD, PhD Public and self-stigma negatively influence patients’ quality of life, employment, and housing opportunities. AMA J Ethics. 2021;23(7):E530-536. doi: 10.1001/amajethics.2021.530. Medicine and Society Jul 2021 Questioning Biomedicine’s Privileging of Disease and Measurability Camille Kroll, MA Adhering too strictly to biomedical thinking about diagnosis can prevent clinicians from empathically engaging with patients and helping them navigate their illness experiences. AMA J Ethics. 2021;23(7):E537-541. doi: 10.1001/amajethics.2021.537. Case and Commentary Oct 2021 When Should Neuroendovascular Care for Patients With Acute Stroke Be Palliative? Michael J. Young, MD, MPhil, Robert W. Regenhardt, MD, PhD, Leonard L. Sokol, MD, and Thabele M. Leslie-Mazwi, MD For some patients whose survival is extended by disease-modifying interventions, little guidance about clinical and ethical complexities exist. AMA J Ethics. 2021;23(10):E783-793. doi: 10.1001/amajethics.2021.783. Art of Medicine Jun 2020 How Portraiture Can Help Build Therapeutic Capacity in Patient-Clinician Relationships Mark Gilbert, PhD AMA J Ethics. 2020;22(6):E570-570. doi: 10.1001/amajethics.2020.570. State of the Art and Science Sep 2016 Teamwork in Health Care: Maximizing Collective Intelligence via Inclusive Collaboration and Open Communication Anna T. Mayo, MS and Anita Williams Woolley, PhD Teams are smartest when everyone feels free to speak up and function best when leadership is inclusive and patient-focused. AMA J Ethics. 2016;18(9):933-940. doi: 10.1001/journalofethics.2016.18.9.stas2-1609.
Case and Commentary Jul 2021 How Should Clinicians Minimize Harms and Maximize Benefits When Diagnosing and Treating Disorders Without Biomarkers? Benjamin Tolchin, MD, MS, Dorothy W. Tolchin, MD, EdM, and Michael Ashley Stein, JD, PhD Public and self-stigma negatively influence patients’ quality of life, employment, and housing opportunities. AMA J Ethics. 2021;23(7):E530-536. doi: 10.1001/amajethics.2021.530.
Medicine and Society Jul 2021 Questioning Biomedicine’s Privileging of Disease and Measurability Camille Kroll, MA Adhering too strictly to biomedical thinking about diagnosis can prevent clinicians from empathically engaging with patients and helping them navigate their illness experiences. AMA J Ethics. 2021;23(7):E537-541. doi: 10.1001/amajethics.2021.537.
Case and Commentary Oct 2021 When Should Neuroendovascular Care for Patients With Acute Stroke Be Palliative? Michael J. Young, MD, MPhil, Robert W. Regenhardt, MD, PhD, Leonard L. Sokol, MD, and Thabele M. Leslie-Mazwi, MD For some patients whose survival is extended by disease-modifying interventions, little guidance about clinical and ethical complexities exist. AMA J Ethics. 2021;23(10):E783-793. doi: 10.1001/amajethics.2021.783.
Art of Medicine Jun 2020 How Portraiture Can Help Build Therapeutic Capacity in Patient-Clinician Relationships Mark Gilbert, PhD AMA J Ethics. 2020;22(6):E570-570. doi: 10.1001/amajethics.2020.570.
State of the Art and Science Sep 2016 Teamwork in Health Care: Maximizing Collective Intelligence via Inclusive Collaboration and Open Communication Anna T. Mayo, MS and Anita Williams Woolley, PhD Teams are smartest when everyone feels free to speak up and function best when leadership is inclusive and patient-focused. AMA J Ethics. 2016;18(9):933-940. doi: 10.1001/journalofethics.2016.18.9.stas2-1609.